MariMed Inc. announced that it has named Charles Finnie as its Chief Strategy Officer, effective from November 7, 2018. Finnie, who most recently was Wall Street’s only research analyst focused solely on cannabis, will lead MariMed’s M&A, strategic investment, and investor relations strategies.